The Outlook for Pharmaceuticals in South East Asia

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

BDH Industries Ltd. (Symbol:524828) SWOT Analysis, Strategy, Revenues and Profits

BDH Industries Ltd. (Symbol:524828) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BDH Industries Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Philippines, India, Australia, Switzerland, Sri Lanka, Singapore

Hiran Orgochem Ltd. (Symbol:506170) SWOT Analysis, Strategy, Revenues and Profits

Hiran Orgochem Ltd. (Symbol:506170) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Hiran Orgochem Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Philippines, Asia, Singapore, Indonesia, Bangladesh, Yemen, Vietnam, South Korea, Pakistan, Malaysia, Jordan, Japan, Israel, India

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary CCM Duopharma Biotech Bhd. (CCM Duopharma) is an investment holding company. The company conducts manufacturing, distributing, importing, and exporting of pharmaceutical products and medicines. It offers products that include analgesic and anti-pyretics, oral antibiotics, cough preparations, ...

Industries: Drug and Medication | Countries: Yemen, Asia, Papua New Guinea, Sri Lanka, Singapore, Bangladesh

Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

Surya Pharmaceutical Limited (SURYAPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Surya Pharmaceutical Limited (Surya Pharmaceutical) is a pharmaceutical company. The company discovers, produces and markets active pharmaceutical ingredients (APIs), finished drug formulations (FDFs), fine intermediates, herbal products, and mint/menthol derivatives. Its research and development ...

Industries: Drug and Medication | Countries: Singapore, United States

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 129 pages

BMI View: Singapore is a low risk pharmaceutical industry thanks to political stability and pro-business policies that continue to attract risk adverse investors. Despite high per capita expenditure on healthcare and a developed healthcare system, the small population size will limit long-term industry ...

Industries: Drug and Medication | Countries: Singapore

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020

  • $ 7 995
  • Industry report
  • by Global Data
  • July 2014
  • 188 pages

OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million ...

Industries: Drug and Medication | Countries: Singapore, Brazil, India, Mexico, Thailand, World

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • May 2014
  • 131 pages

Includes 3 FREE quarterly updates BMI View: The reduction in healthcare subsidies for permanent residents (PRs) in Singapore, which is to be implemented in two phases over the coming 12 months, is a politically driven move rather than a genuine restructuring of the public healthcare system. The policy ...

Industries: Drug and Medication | Countries: Singapore

Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 39 pages

Summary Emcure Pharmaceuticals Ltd. (Emcure) is a pharmaceutical company. The company develops, manufactures and markets health care products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante, Neuroscience, Global HIV, Pharma, Gennova, Oncocare, and APIs. Emcure offers APIs such as acamprosate ...

Industries: Drug and Medication | Countries: India, World, Singapore, South Africa

NRT Smoking Cessation Aids Market Overview in Singapore

NRT Smoking Cessation Aids Market Overview in Singapore

  • $ 718
  • Industry report
  • by Euromonitor International
  • May 2014
  • 21 pages

In April 2010, the Ministry of Health (MOH) made changes to the Smoking (Control of Advertisements and Sale of Tobacco) Act in Parliament. The objective of the amendment bill was to strengthen tobacco control. The main changes included more stringent regulations on the import and distribution of tobacco ...

Industries: Drug and Medication | Countries: Singapore

Analgesics Market Overview in Singapore

Analgesics Market Overview in Singapore

  • $ 718
  • Industry report
  • by Euromonitor International
  • May 2014
  • 26 pages

Topical analgesics brands were aggressively industry ed in 2010, which contributed to their better performance compared to systemic analgesics. Salonpas, which is industry ed by Hisamitsu Pharmaceutical Co Inc, launched a major industry ing campaign in 2010. Even brands such as Axe, which did not engage ...

Industries: Drug and Medication | Countries: Singapore

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.